Navigation Links
NSAID Painkillers Linked to Risk of Kidney Cancer
Date:9/12/2011

By Steven Reinberg
HealthDay Reporter

MONDAY, Sept. 12 (HealthDay News) -- The long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) such as Advil, Motrin and Aleve may slightly increase the risk for developing kidney cancer, Harvard researchers report.

Millions of people use these drugs regularly for pain and they have been associated with reducing the risk of some cancers, the researchers added.

"NSAIDs have been associated with a reduced risk of several types of cancer, including colorectal, breast and prostate," said lead researcher Eunyoung Cho, an assistant professor of medicine at Brigham and Women's Hospital and Harvard Medical School. "Our study raises a contradicting possibility that non-aspirin NSAIDs may elevate the risk of certain types of cancer."

"If our studies are confirmed, risks and benefits should be considered in deciding whether to use analgesics, especially for long duration," she added.

The report was published in the Sept. 12 issue of the Archives of Internal Medicine.

The researchers began the study because there was some epidemiological evidence, mainly from small case-control studies, of a link between the prolonged use of analgesics (pain-relieving medicines) and kidney cancer.

For the study, Cho's team collected data on 77,525 women and 49,403 men who took part in the Nurses' Health Study and the Health Professionals Follow-up Study. Among these individuals, the researchers looked for an association between kidney cancer and the use of different types of pain-relievers.

Specifically, they looked at the incidence of renal cell cancer, which accounts for about 85 percent of all kidney cancers. They also looked for other risk factors for kidney cancer, such as weight, smoking, physical activity and high blood pressure.

Over 16 years of follow-up for the women and 20 years for the men, there were 333 cases of renal cell cancer.

Although there was no association found between the risk for renal cell cancer and aspirin and acetaminophen use, there was an increased between regular use of non-aspirin NSAIDs and renal cell cancer. That resulted in a 51 percent increase in the relative risk of developing the condition, the researchers noted.

In addition, the risk was 19 percent lower if these drugs were used for less than four years. For those who used non-aspirin NSAIDs regularly for four to 10 years the risk for renal cell cancer increased 36 percent and went up almost three times for those who used these drugs regularly for 10 years or more, Cho's group found.

Eric Jacobs, strategic director of pharmacoepidemiology at the American Cancer Society, said that "this well-designed study adds to the evidence that long-term regular use of non-aspirin NSAIDs, such as ibuprofen or naproxen, may modestly increase risk of kidney cancer."

To put the result into perspective, kidney cancer is not especially common and all pain relievers have potential risks that need to be considered, he said. "Two important causes of kidney cancer are obesity and smoking, so maintaining a healthy weight and not smoking will greatly reduce risk of developing this cancer," Jacobs added.

Another expert, Dr. Matthew Galsky, an assistant professor of medicine, hematology, medical oncology and urology at Mount Sinai Medical Center in New York City, doesn't think most people taking NSAIDs have to worry.

"The absolute risk is really on the small side. It's nine to 10 per 100,000 person years," he said. "So many patients take these medications and so many benefit from them; the risk is really on the small side."

Most patients taking NSAIDs don't need to worry, Galsky said. "For the average user of non-aspirin NSAIDs the risk is not of significance; for the person taking these medicines daily for over 10 years, it is food for thought," he said.

More information

For more on kidney cancer, visit the U.S. National Library of Medicine.

SOURCES: Eunyoung Cho, Sc.D., assistant professor, medicine, Brigham and Women's Hospital and Harvard Medical School, Boston; Matthew Galsky, M.D., assistant professor, medicine, hematology, medical oncology and urology, Mount Sinai Medical Center, New York City; Eric Jacobs, Ph.D., strategic director, pharmacoepidemiology, American Cancer Society; Sept. 12, 2011, Archives of Internal Medicine


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. NSAIDs Wont Shield Against Skin Cancer
2. NT-proBNP is a predictor of CV risk in arthritis patients taking NSAIDs
3. Pitt study finds NSAIDs cause stem cells to self-destruct, preventing colon cancer
4. Long-term NSAID use by hypertensive patients with CAD increases risk of adverse events
5. NSAIDs May Raise Miscarriage Risk: Study
6. Painkillers Lower Estrogen Levels, May Explain Cancer Reduction Risk
7. Another perk of painkillers? Decreased hormone levels may reduce cancer risk
8. Statins, Painkillers May Upset PSA Test Results
9. Painkillers in Pregnancy May Harm Sons Fertility, Study Suggests
10. Prescriptions for Stimulants, Painkillers Soaring Among Youth
11. Oxycontin, Other Opioid Painkillers Tied to Higher Health Risks
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NSAID Painkillers Linked to Risk of Kidney Cancer 
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016   Bay Area Lyme Foundation ... Dean Center for Tick Borne Illness , Harvard ... MIT Hacking Medicine, University of California, Berkeley, and ... the five finalists of Lyme Innovation , ... than 100 scientists, clinicians, researchers, entrepreneurs, and investors ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American Respiratory ... testing company, is now able to perform sophisticated lung assessments in ... Medical Technologies , Inc. Patients are no longer ... to ndd,s EasyOne PRO ® , ARL patients like Jeanne R. ... testing done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
Breaking Medicine Technology: